Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angiotensin-II as Second Vasopressor in Septic Shock
NCT06122987Phase 4Recruiting
- Sponsor
- Kingman Regional Medical Center
- Start
- Dec 2023
- Primary completion
- Dec 2024
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Angiotensin II in septic shock, sponsored by Kingman Regional Medical Center. Started Dec 2023; status: recruiting.
02
Drugs
Angiotensin II
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT06122987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06122987.